Beam Therapeutics(MX:BEAM)
MX$492.00-46.00 (-8.55%)
MX:BEAM
Beam Therapeutics financials statements
MX$492.00
At close:-46.00 (-8.55%)
Beam Therapeutics (BEAM) Financial Statements
0 Followers
Beam Therapeutics Financial Overview
Beam Therapeutics's market cap is currently $48.41B. The company's EPS TTM is $-1.00; its P/E ratio is -25.15; Beam Therapeutics is estimated to report earnings on March 2, 2027, and the estimated EPS forecast is $-23.16. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 139.74M | $ 63.52M | $ 377.71M | $ 60.92M | $ 51.84M |
| Gross Profit | $ 117.45M | $ -304.04M | $ 377.71M | $ -250.67M | $ -180.29M |
| Operating Income | $ -383.69M | $ -415.57M | $ -176.49M | $ -338.48M | $ -392.46M |
| EBITDA | $ -13.96M | $ -354.78M | $ -111.15M | $ -271.53M | $ -230.06M |
| Net Income | $ -79.99M | $ -376.74M | $ -132.53M | $ -289.09M | $ -370.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.25B | $ 850.74M | $ 1.19B | $ 1.08B | $ 965.65M |
| Total Assets | $ 1.48B | $ 1.10B | $ 1.46B | $ 1.34B | $ 1.47B |
| Total Debt | $ 293.88M | $ 161.43M | $ 172.69M | $ 179.00M | $ 147.64M |
| Net Debt | $ -1.06M | $ -120.54M | $ -263.21M | $ -53.76M | $ -412.35M |
| Total Liabilities | $ 242.82M | $ 370.28M | $ 478.38M | $ 608.24M | $ 647.72M |
| Stockholders' Equity | $ 1.24B | $ 733.54M | $ 981.33M | $ 733.47M | $ 826.74M |
| Cash Flow | |||||
| Free Cash Flow | $ -360.05M | $ -356.19M | $ -182.93M | $ -26.42M | $ -113.08M |
| Operating Cash Flow | $ -345.10M | $ -347.25M | $ -149.19M | $ 22.53M | $ -66.27M |
| Investing Cash Flow | $ -121.44M | $ 185.01M | $ 71.84M | $ -461.34M | $ -294.14M |
| Financing Cash Flow | $ 478.05M | $ 7.74M | $ 276.45M | $ 111.59M | $ 756.14M |
Currency in USD
